Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From signal/noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoring.
Krucoff MW, Green CL, Harrell FE, Simoons ML, Wilderman NM, Trollinger KM, Sawchak ST, Pope JE, Shah A, Granger CB, et al. Krucoff MW, et al. Among authors: simoons ml. J Electrocardiol. 1994;27 Suppl:233-7. doi: 10.1016/s0022-0736(94)80097-9. J Electrocardiol. 1994. PMID: 7884367 No abstract available.
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Langer A, Krucoff MW, Klootwijk P, Veldkamp R, Simoons ML, Granger C, Califf RM, Armstrong PW. Langer A, et al. Among authors: simoons ml. J Am Coll Cardiol. 1995 Jun;25(7):1552-7. doi: 10.1016/0735-1097(95)00110-p. J Am Coll Cardiol. 1995. PMID: 7759706 Free article. Clinical Trial.
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
Langer A, Krucoff MW, Klootwijk P, Simoons ML, Granger CB, Barr A, Califf RM, Armstrong PW. Langer A, et al. Among authors: simoons ml. J Am Coll Cardiol. 1998 Mar 15;31(4):783-9. doi: 10.1016/s0735-1097(97)00544-5. J Am Coll Cardiol. 1998. PMID: 9525547 Free article.
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.
Mahaffey KW, Granger CB, Sloan MA, Green CL, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM. Mahaffey KW, et al. Among authors: simoons ml. Am Heart J. 1999 Sep;138(3 Pt 1):493-9. doi: 10.1016/s0002-8703(99)70152-3. Am Heart J. 1999. PMID: 10467200 Clinical Trial.
Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.
Akkerhuis KM, Maas AC, Klootwijk PA, Krucoff MW, Meij S, Califf RM, Simoons ML. Akkerhuis KM, et al. Among authors: simoons ml. J Electrocardiol. 2000 Apr;33(2):127-36. doi: 10.1016/s0022-0736(00)80069-2. J Electrocardiol. 2000. PMID: 10819406 Clinical Trial.
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, Wagner GS, Granger CB, Califf RM, Topol EJ, Simoons ML, Armstrong PW. Goodman SG, et al. Among authors: simoons ml. Circulation. 1998 Feb 10;97(5):444-50. doi: 10.1161/01.cir.97.5.444. Circulation. 1998. PMID: 9490238 Clinical Trial.
533 results